Xultophy, Insulin Degludec And Liraglutide, Injection, For Subcutaneous Use, Prefilled Pens - 5 Pens

Xultophy combines two diabetes medications, Insulin Degludec and Liraglutide, to help control blood sugar levels. Insulin Degludec provides long-acting insulin to mimic the body's natural insulin release, while Liraglutide stimulates the release of insulin and reduces glucose production.

Xultophy is indicated for the treatment of adults with type 2 diabetes mellitus to improve glycemic control when diet and exercise alone do not provide adequate control. It is used in combination with diet and exercise.

Always take this medicine exactly as your doctor or healthcare provider has instructed.
Check with your doctor if you are unsure about the dosing instructions.
The recommended dose is usually administered once daily.
Follow your doctor's instructions on dose adjustments, if necessary.
If you accidentally take more than prescribed, seek medical advice immediately.
If you miss a dose, take it as soon as you remember, unless it's close to your next scheduled dose. Do not double up on doses.

Xultophy may cause side effects, although they are not common in everyone. Some possible side effects may include:

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using Xultophy. Your healthcare provider will assess the potential risks and benefits of using this medication during pregnancy and breastfeeding.

Ensure you shake the pen well before use.
Use the pen immediately after opening.
Do not exceed the recommended daily dosage as prescribed by your healthcare provider.
Discuss the use of dietary supplements with your pharmacist or physician.
Xultophy should not be used as a substitute for a balanced diet.
Not recommended for pregnant and breastfeeding women.

Xultophy

1 result for Xultophy